Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,127 | 13,403 | 17,539 | 14,848 | 2,040 |
| TOTAL | $11,655 | $14,704 | $19,164 | $16,545 | $2,283 |
| Non-Current Assets | |||||
| PPE Net | 15 | 16 | 16 | 17 | N/A |
| Intangibles | 80,129 | 81,762 | 77,593 | 77,523 | 0 |
| Other Non-Current Assets | 193 | 210 | 212 | 224 | 0 |
| TOTAL | $80,337 | $81,988 | $77,821 | $77,764 | $N/A |
| Total Assets | $91,993 | $96,693 | $96,985 | $94,308 | $2,283 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 585 | 498 | 1,154 | 1,232 | 455 |
| Accrued Expenses | 1,958 | 1,333 | 1,376 | 1,895 | 879 |
| TOTAL | $2,597 | $1,885 | $2,580 | $3,176 | $1,334 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 15,381 | N/A |
| Other Non-Current Liabilities | 120 | 133 | 141 | 155 | 0 |
| TOTAL | $12,011 | $12,267 | $11,656 | $26,851 | $N/A |
| Total Liabilities | $14,608 | $14,152 | $14,236 | $30,027 | $1,334 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,293 | 1,911 | 1,911 | 1,911 | 1,332 |
| Retained earnings | -104,296 | -88,551 | -84,744 | -73,819 | -66,091 |
| Other shareholders' equity | 108,522 | 100,090 | 96,556 | 70,243 | -299 |
| TOTAL | $77,385 | $82,541 | $82,749 | $64,281 | $949 |
| Total Liabilities And Equity | $91,993 | $96,693 | $96,985 | $94,308 | $2,283 |